S.1695 - Biologics Price Competition and Innovation Act of 2007

A bill to amend the Public Health Service Act to establish a pathway for the licensure of biosimilar biological products, to promote innovation in the life sciences, and for other purposes. view all titles (2)

Close

All Bill Titles

  • Short: Biologics Price Competition and Innovation Act of 2007 as introduced.
  • Official: A bill to amend the Public Health Service Act to establish a pathway for the licensure of biosimilar biological products, to promote innovation in the life sciences, and for other purposes. as introduced.

This Bill currently has no wiki content. If you would like to create a wiki entry for this bill, please Login, and then select the wiki tab to create it.

06/28/07
Senate Committee Passes Follow-On Biologics Bill

The Biologics Price Competition and Innovation Act, S. 1695, allows the FDA to use its scientific discretion in approving products that are biosimilar to ...

Source: FDA news (subscription), VA
06/27/07
Panel OKs Bill to Spur Generic Versions of Biotech Drugs

... amendments from both sides, preserving what they described as a delicate compromise on the legislation ( S 1695 ), which was approved by voice vote. ...

Source: Congressional Quarterly, DC
Information made available by Daily Life

Bill's Views

  • Today: 1
  • Past Seven Days: 7
  • All-Time: 973

-%

Users Support Bill

in favor / opposed
Write Your Senators
Track with MyOC

OpenCongress is a free and open-source joint project of two non-profit organizations, the Participatory Politics Foundation and the Sunlight Foundation.